Fig. 2From: Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institutionOverall (a) and disease-free (b) survival for all patients with early-stage OPSCC seen at the London Health Sciences Centre by p16 status (27 patients p16 negative; 142 patients p16 positive; 26 patients with unknown status were excluded)Back to article page